ProQR Therapeutics N.V.
PRQR
$1.47
-$0.06-3.92%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -47.91% | 19.30% | 6.91% | -30.32% | -6.93% |
| Total Depreciation and Amortization | 0.76% | 0.75% | 2.40% | 7.37% | -0.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.60% | 12.55% | -5.59% | 326.33% | 287.05% |
| Change in Net Operating Assets | 101.67% | -108.70% | -168.82% | 81.10% | -1,121.98% |
| Cash from Operations | 17.74% | -8.70% | -10.55% | 22.17% | -66.84% |
| Capital Expenditure | 69.26% | -209.87% | -72.43% | 51.38% | -66.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 69.26% | -209.87% | -72.43% | 51.38% | 92.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 49.42% | -35.36% | -51.54% | 48.32% | -124.11% |
| Issuance of Common Stock | -- | -- | -- | -- | -99.91% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 49.96% | -34.33% | -56.12% | 36.81% | -100.69% |
| Foreign Exchange rate Adjustments | 2,260.71% | 135.18% | 95.89% | -95.13% | -165.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 22.84% | -11.85% | -4.91% | 19.73% | -127.96% |